These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3963)

  • 41. Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension.
    Bühler FR; Burkart F; Lütold BE; Küng M; Marbet G; Pfisterer M
    Am J Cardiol; 1975 Oct; 36(5):653-69. PubMed ID: 242209
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of changes of posture, beta-blocking agents and the cold pressure test on the levels of plasma renin activity (PRA) in essential hypertension with low serum renin].
    Del Guercio R; Gentile S; Saponara A; De Buono AF
    Clin Ter; 1980 Sep; 94(6):627-34. PubMed ID: 6109590
    [No Abstract]   [Full Text] [Related]  

  • 43. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
    McDevitt DG; Brown HC; Carruthers SG; Shanks RG
    Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sympathetic responsiveness and antihypertensive effect of beta-receptor blockade in essential hypertension.
    Distler A; Keim HJ; Cordes U; Philipp T; Wolff HP
    Am J Med; 1978 Mar; 64(3):446-51. PubMed ID: 25017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction between oxprenolol and indomethacin on blood pressure in essential hypertensive patients.
    Salvetti A; Arzilli F; Pedrinelli R; Beggi P; Motolese M
    Eur J Clin Pharmacol; 1982; 22(3):197-201. PubMed ID: 7049707
    [TBL] [Abstract][Full Text] [Related]  

  • 46. "24-hour blood pressure control" with sustained release oxprenolol 160mg plus cyclopenthiazide 0.25mg (Trasidrex) in general practice.
    Forrest WA; Bridgman KM; Ebbutt AF
    Br J Clin Pract; 1983; 37(11-12):385-8. PubMed ID: 6367794
    [No Abstract]   [Full Text] [Related]  

  • 47. Single administration of captopril and combined use with beta-blocker and/or thiazide diuretic in the treatment of essential hypertension.
    Yoneda S; Kako T; Koketsu M; Hayano J; Asakawa T; Fujinami T; Kato T
    Angiology; 1991 Nov; 42(11):914-23. PubMed ID: 1683186
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of oxprenolol on catecholamines and plasma renin activity: acute response to frusemide in hypertensive patients.
    Muiesan G; Alicandri C; Rosei EA; Motolese M; Valori C
    Clin Sci Mol Med Suppl; 1975 Jun; 2():85s-88s. PubMed ID: 802648
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intrinsic sympathomimetic activity counteracts beta-blocker inhibition of renin activation.
    Ruddy MC; Bialy GB; Kostis JB
    Angiology; 1989 Jan; 40(1):45-50. PubMed ID: 2562912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of oxprenolol on the intra-arterial blood pressure response to dynamic exercise in hypertensive men.
    Millar-Craig MW; Mann S; Balasubramanian V; Cashman P; Raftery EB
    J Cardiovasc Pharmacol; 1981; 3(3):468-76. PubMed ID: 6168828
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bucindolol, a beta-adrenoceptor blocker with vasodilatory action: its effect in systemic hypertension.
    Rotmensch HH; Rocci ML; Vlasses PH; Swanson BN; Fedder IL; Soyka L; Ferguson RK
    Am J Cardiol; 1984 Aug; 54(3):353-6. PubMed ID: 6147080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [2 antihypertensive therapeutic regimes compared in a controlled clinical trial in general practice. Cyclopenthiazide + KC1/methyldopa versus oxprenolol/hydralazine].
    Gyntelberg F; Jacobsen K; Martlev A; Backer P
    Ugeskr Laeger; 1977 Mar; 139(11):641-6. PubMed ID: 320734
    [No Abstract]   [Full Text] [Related]  

  • 53. The treatment of hypertension in older patients: a comparative study between a diuretic, a beta-receptor antagonist and their fixed combination.
    Forrest WA
    Practitioner; 1982 Apr; 226(1366):777-8. PubMed ID: 7045851
    [No Abstract]   [Full Text] [Related]  

  • 54. Plasma concentration and antihypertensive effect of beta-receptor blockers.
    Hitzenberger G
    Cardiology; 1979; 64 Suppl 1():14-9. PubMed ID: 42485
    [No Abstract]   [Full Text] [Related]  

  • 55. Disparate hemodynamic responses to mental challenge after antihypertensive therapy with beta blockers and calcium entry blockers.
    Schmieder RE; Rueddel H; Neus H; Messerli FH; Von Eiff AW
    Am J Med; 1987 Jan; 82(1):11-6. PubMed ID: 2879457
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lack of beta-adrenoreceptor hypersensitivity after abrupt withdrawal of long-term therapy with oxprenolol.
    Bolli P; Bühler FR; Raeder EA; Amann FW; Meier M; Rogg H; Burckhardt D
    Circulation; 1981 Dec; 64(6):1130-4. PubMed ID: 6117379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hemodynamic effects of oxprenolol and propranolol in hypertension.
    Franciosa JA; Johnson SM; Tobian LJ
    Clin Pharmacol Ther; 1979 Dec; 26(6):676-81. PubMed ID: 387330
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of mild to moderate hypertension: diuretic or beta-blockers?
    Nomura G; Arai S; Maekawa M; Ohta H; Takabatake T
    Jpn Circ J; 1981 Jul; 45(7):826-32. PubMed ID: 7021900
    [No Abstract]   [Full Text] [Related]  

  • 60. Haemodynamic consequences of intrinsic sympathomimetic activity and cardioselectivity in beta-blocker therapy for hypertension.
    Man in 't Veld AJ; Schalekamp MA
    Eur Heart J; 1983 Jul; 4 Suppl D():31-41. PubMed ID: 6137381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.